Chrissie E B Ong

3PUBLICATIONS
9CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 19, 2022
Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours.

Chrissie E B Ong, Yuanyuan Cheng, Hannah V Siddle

|Apr 02, 2021
NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers.

Chrissie E B Ong, Amanda L Patchett, Jocelyn M Darby

Pageof 1